Skip to content New The AI buying guide for BD&L executives — now available on demand Watch
Resources

Latest thinking

Scientific insights, BD frameworks, and the reasoning behind assessments — written for the people who have to defend the decision.
Featured · Scientific insight

Scientific insights: Why China Now Owns the Late-Stage IL-4R Pipeline

Chinese companies now run seven of the eight IL-4Rα assets in Phase III — and the eighth is licensed to China too, with MG-K10’s latest Phase III data (94.3% EASI-75 at week 52) showing exactly why this comp set can’t be ignored. The unmet need is real. Even with three approved biologics, roughly half of SLE patients hit a meaningful composite response at one year, and sustained remission is rare. TLR7 sits genetically upstream of the interferon axis that drives ~75% of disease — a clean, well-validated target.

Scientific insights
News

Orphan Therapeutics Accelerator Announces Foundational Partnerships

The Orphan Therapeutics Accelerator, a non-profit biotech organization focused on completing development and commercializing therapies for ultra-rare conditions News
News

The Impact Review – Founding Vibe Bio

The Impact Review article explores Alok Tayi’s personal experience with rare disease drove him towards a mission – to fund cures for rare diseases. News
News

STAT – Upending drug industry financing

This article looks at how Vibe Bio CEO, Alok Tayi, is seeking to upend drug industry financing. News
News

Forbes – Alok Tayi’s new start-up is putting drug development into patients’ hands

This article examines how Vibe Bio’s Founder and CEO is putting drug development into patients’ hands. News
News

Endpoint News – Parents become drug developers to save their children’s lives

Endpoint News addressed how parents of children with rare disease are challenging the status quo in drug development. News
News

Coindesk – How Vibe Bio plans to retool biotech funding

In this article, Vibe Bio founder and CEO, Alok Tayi, explains how a decentralized science approach can retool biotech funding. News
News

The Scoop – A conversation with Alok Tayi

“In this episode of The Scoop, Tayi shares his vision for how Vibe Bio aims to disrupt the centralized control of big pharma” Podcasts

Get the latest thinking as it publishes

"*" indicates required fields

This field is for validation purposes and should be left unchanged.